Supplements
New evidence of the dual inhibition renin-angiotensin-aldosterone system (RAAS)
Xavier Díez
Medwave 2010;10(11):e4813
( 1/12/2010)
Rationale for combination therapy in the treatment of hypertension
Luis Alcocer
Medwave 2010;10(11):e4807
( 1/12/2010)
Current evidence on the combination of a direct renin inhibitor and an ARB or ACE inhibitor
Javier Díez
Medwave 2010;10(11):e4808
( 1/12/2010)
Fixed combinations for the treatment of hypertension
Alejandro Yenes Moerbeck
Medwave 2010;10(11):e4811
( 1/12/2010)
Receivers of de novo renal transplant treated with Myfortic, Simulect and reduced exposure to CsA
Klemens Budde
Medwave 208;8(08):e1668
( 1/09/2008)
Results of an initial intensive dosing regimen with Myfortic ® in de novo transplant
Klemens Budde
Medwave 208;8(07):e558
( 1/08/2008)
Hypertension: an unsolved public health problem
Luis Hernán Zárate
Medwave 208;8(06):e509
( 1/07/2008)
New horizons in the treatment of hypertension: pharmacological modulation of plasma renin
Roberto Jalil M.
Medwave 208;8(06):e510
( 1/07/2008)
Aliskiren: innovation in the inhibition of the renin-angiotensin
Antonio Coca
Medwave 208;8(06):e516
( 1/07/2008)
New approaches for de-escalation therapy in the ICU: getting it right from start to finish
Nicholas Namias
Medwave 203;3(06):e1722
( 1/07/2003)
New strategies in the treatment of chronic hepatitis C
David Kershenovich
Medwave 203;3(06):e1729
( 1/07/2003)